Cue Biopharma Inc (CUE)
0.98
-0.10
(-9.26%)
USD |
NASDAQ |
Jul 03, 16:00
Cue Biopharma Revenue (Annual): 5.49M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 5.49M |
December 31, 2022 | 1.245M |
December 31, 2021 | 14.94M |
Date | Value |
---|---|
December 31, 2020 | 3.154M |
December 31, 2019 | 3.458M |
December 31, 2018 | 1.143M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.245M
Minimum
2022
14.94M
Maximum
2021
5.658M
Average
3.458M
Median
2019
Revenue (Annual) Benchmarks
XOMA Corp | 4.758M |
Ardelyx Inc | 124.46M |
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 4.854M |
iBio Inc | -- |